Lunai Bioworks & BrainStorm Therapeutics Launch Foundation-Funded Parkinson’s & Rare Epilepsy AI Discovery Collaboration
SACRAMENTO, CA, UNITED STATES, May 28, 2026 — Collaboration integrates AI discovery, human brain organoid modeling, and in vivo validation to generate differentiated neurology assets for pharmaceutical partnering and development Lunai Bioworks’ (NASDAQ: LNAI) wholly owned subsidiary BioSymetrics and…